Repeat cytoreductive surgery with or without intraperitoneal chemotherapy for recurrent epithelial appendiceal neoplasms.


Journal

BJS open
ISSN: 2474-9842
Titre abrégé: BJS Open
Pays: England
ID NLM: 101722685

Informations de publication

Date de publication:
06 2020
Historique:
received: 28 08 2019
accepted: 19 12 2019
pubmed: 6 2 2020
medline: 25 5 2021
entrez: 6 2 2020
Statut: ppublish

Résumé

With recurrence rates after primary cytoreductive surgery (CRS) in excess of 50 per cent, repeat CRS is being performed increasingly, but survival outcomes have not been reported widely. This study examined the outcomes following repeat CRS for appendiceal cancer with peritoneal surface malignancy (PSM), and evaluated its feasibility and safety. A retrospective cohort of patients who had surgery between 1996 and 2018 were analysed. Patients who underwent a single CRS procedure with or without heated intraperitoneal chemotherapy (HIPEC) were compared with those who had multiple procedures with or without HIPEC. Perioperative morbidity and survival outcomes were analysed. Some 462 patients were reviewed, 102 of whom had repeat procedures. For high-grade tumours, patients who had a single CRS procedure had significantly reduced overall survival (OS) compared with those who had repeat CRS (55·6 versus 90·7 months respectively; P = 0·016). For low-grade tumours, there was no difference in OS (P = 0·153). When patients who had a single procedure were compared with those who had multiple procedures, there was no significant difference in major morbidity (P = 0·441) or in-hospital mortality (P = 0·080). For multiple procedures, no differences were found in major morbidity (P = 0·262) or in-hospital mortality (P = 0·502) when the first procedure was compared with the second. For low-grade cancers, the peritoneal carcinomatosis index was a significant prognostic factor for OS (hazard ratio (HR) 1·11, 95 per cent c.i. 1·05 to 1·17; P < 0·001), whereas for high-grade cancers repeat CRS (HR 0·57, 0·33 to 0·95; P = 0·033), complete cytoreduction score (HR 1·55, 1·01 to 2·40; P = 0·046) and presence of signet ring cells (HR 2·77, 1·78 to 4·30; P < 0·001) were all significant indicators of long-term survival. In selected patients presenting with PSM from epithelial appendiceal neoplasms, repeat CRS performed in high-volume centres could provide survival benefits. En países de bajos y medianos ingresos (low- and middle-income countries, LMIC) hay que desarrollar estrategias de futuro para incrementar la disponibilidad de equipos quirúrgicos, adquisición, capacitación, uso, mantenimiento y complicaciones relacionadas con las unidades electroquirúrgicas (electrosurgical unit, ESU) y los equipos de laparoscopia. MÉTODOS: Se realizó una encuesta entre los cirujanos que asistieron a la reunión anual del Colegio de Cirujanos de África Oriental, Central y Meridional (College Of Surgeons of East, Central and Southern Africa, COSECSA) en diciembre de 2017 y a la reunión anual de la Sociedad Quirúrgica de Kenia (Surgical Society of Kenya, SSK) en marzo de 2018. Se encuestaron también a los técnicos de equipos biomédicos (Biomedical Equipment Technicians, BMET) y se recopilaron los registros de mantenimiento en Kenia entre febrero y marzo de 2018. Participaron 80 sujetos, 59 cirujanos de 11 países africanos y 21 BMET de Kenia. Se recopilaron 36 registros de mantenimiento. Todos los cirujanos de COSECSA y SSK disponían de ESU, pero menos de la mitad (49%) disponían de equipos de laparoscopia. Como principales problemas se detectaron la reutilización de accesorios desechables en las ESU y las dificultades para disponer de CO2. Más de las tres cuartas partes (78%) de los cirujanos contaban con equipos de mantenimiento para las ESU, pero solo el 59% disponía de mantenimiento para los equipos de laparoscopia en su centro. CONCLUSIÓN: A pesar de la disponibilidad de equipos quirúrgicos, en estos LMIC se detectaron serias dificultades en su mantenimiento, hecho que limita la implementación de la cirugía abierta y laparoscópica.

Sections du résumé

BACKGROUND
With recurrence rates after primary cytoreductive surgery (CRS) in excess of 50 per cent, repeat CRS is being performed increasingly, but survival outcomes have not been reported widely. This study examined the outcomes following repeat CRS for appendiceal cancer with peritoneal surface malignancy (PSM), and evaluated its feasibility and safety.
METHODS
A retrospective cohort of patients who had surgery between 1996 and 2018 were analysed. Patients who underwent a single CRS procedure with or without heated intraperitoneal chemotherapy (HIPEC) were compared with those who had multiple procedures with or without HIPEC. Perioperative morbidity and survival outcomes were analysed.
RESULTS
Some 462 patients were reviewed, 102 of whom had repeat procedures. For high-grade tumours, patients who had a single CRS procedure had significantly reduced overall survival (OS) compared with those who had repeat CRS (55·6 versus 90·7 months respectively; P = 0·016). For low-grade tumours, there was no difference in OS (P = 0·153). When patients who had a single procedure were compared with those who had multiple procedures, there was no significant difference in major morbidity (P = 0·441) or in-hospital mortality (P = 0·080). For multiple procedures, no differences were found in major morbidity (P = 0·262) or in-hospital mortality (P = 0·502) when the first procedure was compared with the second. For low-grade cancers, the peritoneal carcinomatosis index was a significant prognostic factor for OS (hazard ratio (HR) 1·11, 95 per cent c.i. 1·05 to 1·17; P < 0·001), whereas for high-grade cancers repeat CRS (HR 0·57, 0·33 to 0·95; P = 0·033), complete cytoreduction score (HR 1·55, 1·01 to 2·40; P = 0·046) and presence of signet ring cells (HR 2·77, 1·78 to 4·30; P < 0·001) were all significant indicators of long-term survival.
CONCLUSION
In selected patients presenting with PSM from epithelial appendiceal neoplasms, repeat CRS performed in high-volume centres could provide survival benefits.
ANTECEDENTES
En países de bajos y medianos ingresos (low- and middle-income countries, LMIC) hay que desarrollar estrategias de futuro para incrementar la disponibilidad de equipos quirúrgicos, adquisición, capacitación, uso, mantenimiento y complicaciones relacionadas con las unidades electroquirúrgicas (electrosurgical unit, ESU) y los equipos de laparoscopia. MÉTODOS: Se realizó una encuesta entre los cirujanos que asistieron a la reunión anual del Colegio de Cirujanos de África Oriental, Central y Meridional (College Of Surgeons of East, Central and Southern Africa, COSECSA) en diciembre de 2017 y a la reunión anual de la Sociedad Quirúrgica de Kenia (Surgical Society of Kenya, SSK) en marzo de 2018. Se encuestaron también a los técnicos de equipos biomédicos (Biomedical Equipment Technicians, BMET) y se recopilaron los registros de mantenimiento en Kenia entre febrero y marzo de 2018.
RESULTADOS
Participaron 80 sujetos, 59 cirujanos de 11 países africanos y 21 BMET de Kenia. Se recopilaron 36 registros de mantenimiento. Todos los cirujanos de COSECSA y SSK disponían de ESU, pero menos de la mitad (49%) disponían de equipos de laparoscopia. Como principales problemas se detectaron la reutilización de accesorios desechables en las ESU y las dificultades para disponer de CO2. Más de las tres cuartas partes (78%) de los cirujanos contaban con equipos de mantenimiento para las ESU, pero solo el 59% disponía de mantenimiento para los equipos de laparoscopia en su centro. CONCLUSIÓN: A pesar de la disponibilidad de equipos quirúrgicos, en estos LMIC se detectaron serias dificultades en su mantenimiento, hecho que limita la implementación de la cirugía abierta y laparoscópica.

Autres résumés

Type: Publisher (spa)
En países de bajos y medianos ingresos (low- and middle-income countries, LMIC) hay que desarrollar estrategias de futuro para incrementar la disponibilidad de equipos quirúrgicos, adquisición, capacitación, uso, mantenimiento y complicaciones relacionadas con las unidades electroquirúrgicas (electrosurgical unit, ESU) y los equipos de laparoscopia. MÉTODOS: Se realizó una encuesta entre los cirujanos que asistieron a la reunión anual del Colegio de Cirujanos de África Oriental, Central y Meridional (College Of Surgeons of East, Central and Southern Africa, COSECSA) en diciembre de 2017 y a la reunión anual de la Sociedad Quirúrgica de Kenia (Surgical Society of Kenya, SSK) en marzo de 2018. Se encuestaron también a los técnicos de equipos biomédicos (Biomedical Equipment Technicians, BMET) y se recopilaron los registros de mantenimiento en Kenia entre febrero y marzo de 2018.

Identifiants

pubmed: 32020757
doi: 10.1002/bjs5.50262
pmc: PMC7260401
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

478-485

Informations de copyright

© 2020 The Authors. BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd.

Références

J Am Coll Surg. 2012 Sep;215(3):412-7
pubmed: 22634117
Ann Surg. 2009 Jun;249(6):900-7
pubmed: 19474692
Int J Clin Oncol. 2018 Apr;23(2):298-304
pubmed: 29181652
J Surg Oncol. 2014 Oct;110(5):575-84
pubmed: 25164477
Eur J Surg Oncol. 2008 Feb;34(2):196-201
pubmed: 17524597
J Gastrointest Oncol. 2016 Feb;7(1):3-9
pubmed: 26941979
Ann Surg. 1995 Jan;221(1):29-42
pubmed: 7826158
J Surg Oncol. 2013 Aug;108(2):81-8
pubmed: 23737041
Cancer Treat Res. 1996;82:359-74
pubmed: 8849962
Ann Surg Oncol. 2017 Jan;24(1):176-183
pubmed: 27718032
World J Surg. 2015 Jun;39(6):1578-83
pubmed: 25651962
J Surg Oncol. 2008 Sep 15;98(4):277-82
pubmed: 18726894
J Surg Oncol. 2008 Sep 15;98(4):295-9
pubmed: 18726900
Ann Surg Oncol. 2007 Aug;14(8):2289-99
pubmed: 17541772
Cancer. 2002 Jun 15;94(12):3307-12
pubmed: 12115365
J Surg Oncol. 2019 Mar;119(3):336-346
pubmed: 30554404
Cancer. 2000 Jan 15;88(2):358-63
pubmed: 10640968
J Clin Oncol. 2012 Jul 10;30(20):2449-56
pubmed: 22614976
Am J Surg. 2017 Jun;213(6):1024-1030
pubmed: 27839689
Clin Colon Rectal Surg. 2015 Dec;28(4):247-55
pubmed: 26648795
Eur J Surg Oncol. 2013 Nov;39(11):1207-13
pubmed: 24007834
J Clin Oncol. 2009 Dec 20;27(36):6237-42
pubmed: 19917862
Ann Surg. 1994 Jan;219(1):51-7
pubmed: 8297177
Ann Surg Oncol. 2019 May;26(5):1445-1453
pubmed: 30825033
Ann Surg Oncol. 2007 Feb;14(2):484-92
pubmed: 17054002
Ann Surg Oncol. 2013 Apr;20(4):1056-62
pubmed: 23456385
Lancet Oncol. 2006 Jan;7(1):69-76
pubmed: 16389186
Ann Surg. 2007 Jan;245(1):104-9
pubmed: 17197972
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
J Am Coll Surg. 2009 Sep;209(3):308-12
pubmed: 19717034
Histopathology. 2017 Dec;71(6):847-858
pubmed: 28746986
Ann Surg. 2001 Aug;234(2):198-205
pubmed: 11505065
Int J Clin Oncol. 2013 Jun;18(3):439-46
pubmed: 22415741

Auteurs

J B Karpes (JB)

Liver and Peritonectomy Unit, St George Hospital, Sydney, New South Wales, Australia.
St George and Sutherland Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

J D Lansom (JD)

Liver and Peritonectomy Unit, St George Hospital, Sydney, New South Wales, Australia.

M Alshahrani (M)

Liver and Peritonectomy Unit, St George Hospital, Sydney, New South Wales, Australia.

R Parikh (R)

Liver and Peritonectomy Unit, St George Hospital, Sydney, New South Wales, Australia.

R Shamavonian (R)

Liver and Peritonectomy Unit, St George Hospital, Sydney, New South Wales, Australia.
St George and Sutherland Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

N A Alzahrani (NA)

Liver and Peritonectomy Unit, St George Hospital, Sydney, New South Wales, Australia.
College of Medicine, Al Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia.

W Liauw (W)

Liver and Peritonectomy Unit, St George Hospital, Sydney, New South Wales, Australia.
Cancer Care Clinic, St George Hospital, Sydney, New South Wales, Australia.

D L Morris (DL)

Liver and Peritonectomy Unit, St George Hospital, Sydney, New South Wales, Australia.
St George and Sutherland Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH